Fortive/$FTV

1D1W1MYTD1Y5YMAX

About Fortive

Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc. It has two reportable segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Maximum revenue is generated from the Intelligent Operating Solutions segment, which offers professional instruments used in applications like maintenance, repair, measurement, and condition monitoring, connected worker safety, compliance solutions, etc. The products and services in this segment are marketed under various brands, including Fluke, Servicechannel, Gordian, Accruent, Industrial Scientific, and Intelex. Geographically, the firm generates maximum revenue from North America.
Ticker
$FTV
Primary listing
NYSE
Employees
10,000

Fortive Metrics

BasicAdvanced
$17B
33.55
$1.68
0.98
$0.24
0.42%

What the Analysts think about Fortive

Analyst ratings (Buy, Hold, Sell) for Fortive stock.
Analyst projections of the future price of Fortive stock.

Bulls say / Bears say

Fortive raised its full‐year 2026 adjusted EPS guidance to $2.95–$3.05 (from $2.90–$3.00) after Q2 revenue grew 8% to $1.1 billion, demonstrating resilience in its industrial automation business. (Yahoo Finance)
In Q2, Fortive generated $270.6 million of non‐GAAP free cash flow (trailing 12‐month free cash flow of $1.044 billion, >100% conversion) and deployed approximately $200 million to repurchase shares, highlighting strong cash generation and disciplined capital allocation. (Fortive Press Release)
Core revenue growth accelerated to 6.7% in Q2 with adjusted EBITDA up 12%, reflecting effective execution of its Fortive Accelerated strategy across Intelligent Operating Solutions and Advanced Healthcare Solutions. (Yahoo Finance)
Fortive’s Q2 filings highlight risks from international trade tensions, supply‐chain constraints and sole‐source dependencies, which could pressure margins and impede growth if geopolitical conditions worsen. (Fortive Press Release)
The Advanced Healthcare Solutions segment delivered only 5.3% core revenue growth in Q2—lagging overall company growth—exposing concentration risk in its reportable segments. (Yahoo Finance)
At a forward P/E of approximately 29.6x for fiscal 2026, Fortive’s valuation is above industry norms, which may cap upside if the company cannot sustain mid‐single‐digit revenue growth. (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 28 Aug 2026.

Fortive Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Fortive Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Fortive

AllUSDEURGBP
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.